Sentence examples for multiple marker screening from inspiring English sources

Objective: Our goal was to evaluate the effectiveness of two approaches to screen pregnancies for trisomy 18. Study Design: We analyzed the outcome of all pregnancies that were screen positive for trisomy 18 by multiple marker screening (α-fetoprotein, unconjugated estriol, and human chorionic gonadotropin) from May 1993 to June 1998.

Multiple marker screening can be performed at 15 20 weeks' gestation.

Women presenting in the second trimester should be offered multiple marker screening as described in the ACMG policy statement entitled Second Trimester Maternal Serum Screening for Fetal Open Neural Tube Defects and Aneuploidy (2004) (www.acmg.net ).net

Based on the current scientific evidence American College of Obstetricians and Gynecologists recommends that patients with a fetal NT measurement of 3.5 mm or higher should be offered a targeted ultrasound, echocardiogram, or both. 1 Multiple marker screening is used in the second trimester (15 20 weeks) to screen for trisomies 21 and 18 as well as ONTDs.

Multiple marker screening in the second trimester does not reliably detect the other forms of aneuploidy that occur more often as result of increasing maternal age, such as trisomy 13 and Klinefelter syndrome (47,XXY) (1 in 20,000 and 1 in 1000 livebirths, respectively).

The purpose of this study was to determine if abnormal multiple marker screens (MMS) are associated with adverse perinatal outcomes in intrauterine growth restriction (IUGR) pregnancies.

However, these data do not preclude the possible utility of these factors in a multiple marker screen for the prediction of preeclampsia.

Maternal serum screen (also called quad screen, triple screen or test, multiple marker screen or AFP) – This is a screening test done at 15 to 20 weeks to detect a higher risk of chromosomal disorders such as Down syndrome and trisomy18 and neural tube defects such as spina bifida.

To evaluate whether a combination of putative markers of inflammation and CA-125 could serve as a multiple-marker screening test for endometriosis in a heterogeneous population of patients.

This is important for women deciding about testing and also a component of multiple-marker screening risk algorithms.

These 100 selected plants should then be screened for the markers that showed DP alleles during marker screening in BC1.